Janko Ignjatović holds a master of pharmacy degree from the Faculty of Pharmacy, University of Belgrade in Serbia. Upon finishing master studies, he continued his academic and scientific development by enrolling in doctoral studies at the module of Drug Analysis at the Faculty of Pharmacy, University of Belgrade, Serbia.
Moreover, his curiosity and motivation to contribute to science and healthcare led him to further expand his expertise and professional development within pharmaceutical companies GSK and Novartis. Furthermore, during his postgraduate development he was declared as individual winner of Regional BioCamp, a forum connecting academics and industry in Ljubljana capital of Slovenia, thus he gained the right to participate in the Global BioCamp which was organized in headquarters of pharmaceutical company Novartis in Basel, Switzerland. There he was selected as an individual winner of the global Novartis BioCamp 2014. For this achievement he was awarded a professional training and a visit at Novartis Institute for Biomedical Research (NIBR) in Beijing and Shanghai in the People’s Republic of China.
Motivated to continue with his passion to foster application of academic knowledge in the industrial field and give his contribution to shaping the healthcare, he pursued a career of research scientist in Novartis global drug development department for biopharmaceutical drugs in Mengeš, Slovenia.
In addition to working in pharmaceutical industry, he enrolled and completed an additional doctorate studies in the field of Biotechnology of the Biotechnical Faculty, University of Ljubljana, where the primary focus of his research is protein aggregation and its potential immunogenicity.
Peptides: Rumored to be Cure for All
Development of new recombinant biotechnology products has greatly expanded in the field of modern pharmacy and medicine. As proteins have a variety of physiological roles in organism, biopharmaceutical drugs that contain biomolecules such as peptides or even complex monoclonal antibodies as active pharmaceutical ingredients, are very selective and effective in treating various diseases. In the lecture Peptides: Rumoured to be Cure for All, Janko Ignjatović will discuss about the development, division and role of biological drugs. Moreover, special attention will be dedicated to the variety of peptides that are available on market and their use in different medical conditions.